HUP9700826A1 - Peptikus fekély elleni gyógyászati készítmények - Google Patents
Peptikus fekély elleni gyógyászati készítményekInfo
- Publication number
- HUP9700826A1 HUP9700826A1 HU9700826A HUP9700826A HUP9700826A1 HU P9700826 A1 HUP9700826 A1 HU P9700826A1 HU 9700826 A HU9700826 A HU 9700826A HU P9700826 A HUP9700826 A HU P9700826A HU P9700826 A1 HUP9700826 A1 HU P9700826A1
- Authority
- HU
- Hungary
- Prior art keywords
- peptic ulcer
- pharmaceutical compositions
- compositions against
- against peptic
- production
- Prior art date
Links
- 208000008469 Peptic Ulcer Diseases 0.000 title abstract 2
- 208000011906 peptic ulcer disease Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- VJVOFLWZDWLHNR-MRCUWXFGSA-N icosan-9-yl (z)-docos-13-enoate Chemical compound CCCCCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCCCCCC\C=C/CCCCCCCC VJVOFLWZDWLHNR-MRCUWXFGSA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000004575 stone Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A találmány tárgya peptikűs fekély elleni gyógyszerkészítmény,valamint eljárás ezek előállítására. A találmány szerinti gyógyászatikészítmények hatóanyagként cink-hialűrőnát asszőciátűmőt/kőmplexet),és önmagában ismert, a gyógyászati készítmények előállításánálszőkásősan alkalmazőtt hőrdőzó és/vagy segédanyagőkat tartalmaznak. ŕ
Priority Applications (29)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9700826A HU225991B1 (en) | 1997-04-29 | 1997-04-29 | Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer |
NZ500978A NZ500978A (en) | 1997-04-29 | 1998-04-28 | Use of zinc hyaluronate complex against peptic ulcer |
KR1019997010037A KR100572190B1 (ko) | 1997-04-29 | 1998-04-28 | 소화성궤양에 대한 아연 히알루로네이트의 사용 |
TW087106525A TW501927B (en) | 1997-04-29 | 1998-04-28 | Pharmaceutical compositions against peptic ulcer |
PL98336482A PL189526B1 (pl) | 1997-04-29 | 1998-04-28 | Farmaceutyczna kompozycja do stosowania doustnegoprzeciw wrzodowi trawiennemu, sposób wytwarzania farmaceutycznej kompozycji oraz zastosowanie asocjatu hialuronianu cynkowego do wytwarzania farmaceutycznej kompozycji |
DE69833937T DE69833937T2 (de) | 1997-04-29 | 1998-04-28 | Verwendung von zinkhyaluronat gegen magengeschwür |
IL13221498A IL132214A0 (en) | 1997-04-29 | 1998-04-28 | Use of zinc hyaluronate against peptic ulcer |
ES98920684T ES2259813T3 (es) | 1997-04-29 | 1998-04-28 | Utilizacion del hialuronato de zinc contra la ulcera peptica. |
CN98804672A CN1126548C (zh) | 1997-04-29 | 1998-04-28 | 透明质酸锌抗消化性溃疡的应用 |
SK1468-99A SK284864B6 (sk) | 1997-04-29 | 1998-04-28 | Použitie komplexu hyaluronátu zinku na prípravu farmaceutickej kompozície proti peptickým vredom |
EEP199900470A EE04953B1 (et) | 1997-04-29 | 1998-04-28 | Tsinkhaluronaadi kasutamine ja meetod ravimkoostise valmistamiseks |
DK98920684T DK1017403T3 (da) | 1997-04-29 | 1998-04-28 | Anvendelse af zinkhyaluronat mod peptisk ulcer |
SI9830830T SI1017403T1 (sl) | 1997-04-29 | 1998-04-28 | Uporaba cinkovega hialuronata proti pepticnemu ulkusu |
AT98920684T ATE320814T1 (de) | 1997-04-29 | 1998-04-28 | Verwendung von zinkhyaluronat gegen magengeschwür |
BR9809354-1A BR9809354A (pt) | 1997-04-29 | 1998-04-28 | Uso de hialuronato de zinco contra úlcera péptica |
EP98920684A EP1017403B1 (en) | 1997-04-29 | 1998-04-28 | Use of zinc hyaluronate against peptic ulcer |
UA99116468A UA62964C2 (en) | 1997-04-29 | 1998-04-28 | Pharmaceutical compositions against peptic ulcer, manufacture process, and method for treating peptic ulcer |
PCT/HU1998/000044 WO1998048815A1 (en) | 1997-04-29 | 1998-04-28 | Use of zinc hyaluronate against peptic ulcer |
EA199900983A EA002134B1 (ru) | 1997-04-29 | 1998-04-28 | Применение комплекса гиалуроната цинка для лечения пептической язвы |
CA002286756A CA2286756C (en) | 1997-04-29 | 1998-04-28 | Use of zinc hyaluronate against peptic ulcer |
US09/403,714 US6656921B1 (en) | 1997-04-29 | 1998-04-28 | Use of zinc hyaluronate against peptic ulcer |
CZ0382799A CZ297317B6 (cs) | 1997-04-29 | 1998-04-28 | Farmaceutická kompozice pro orální pouzití proti peptickému vredu |
AU73468/98A AU749757B2 (en) | 1996-09-12 | 1998-04-28 | Use of zinc hyaluronate against peptic ulcer |
JP54638898A JP2001522361A (ja) | 1997-04-29 | 1998-04-28 | 消化性潰瘍に対するヒアルロン酸亜鉛の利用 |
PT98920684T PT1017403E (pt) | 1997-04-29 | 1998-04-28 | Utilizacao de hialuronato de zinco contra a ulcera peptica |
ZA983626A ZA983626B (en) | 1997-04-29 | 1998-04-29 | Pharmaceutical compositions against peptic ulcer |
BG103822A BG64458B1 (bg) | 1997-04-29 | 1999-10-19 | Използване на цинков хиалуронат срещу пептична язва |
NO19995229A NO328313B1 (no) | 1997-04-29 | 1999-10-26 | Fremgangsmate for fremstilling av et farmasoytisk preparat for oral anvendelse mot peptisk ulcus og anvendelse av sinkhyaluronatassosiat (-kompleks) med en molekylvekt i omradet fra 500 000 dalton til 1 200 000 dalton for fremstilling av farmasoytiske preparater for oral anvendelse mot peptisk ulcus |
HK00104494A HK1025250A1 (en) | 1997-04-29 | 2000-07-20 | Use of zinc hyaluronate against peptic ulcer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9700826A HU225991B1 (en) | 1997-04-29 | 1997-04-29 | Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9700826D0 HU9700826D0 (en) | 1997-06-30 |
HUP9700826A1 true HUP9700826A1 (hu) | 1998-12-28 |
HU225991B1 HU225991B1 (en) | 2008-02-28 |
Family
ID=89995068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9700826A HU225991B1 (en) | 1996-09-12 | 1997-04-29 | Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer |
Country Status (27)
Country | Link |
---|---|
US (1) | US6656921B1 (hu) |
EP (1) | EP1017403B1 (hu) |
JP (1) | JP2001522361A (hu) |
KR (1) | KR100572190B1 (hu) |
CN (1) | CN1126548C (hu) |
AT (1) | ATE320814T1 (hu) |
BG (1) | BG64458B1 (hu) |
BR (1) | BR9809354A (hu) |
CA (1) | CA2286756C (hu) |
CZ (1) | CZ297317B6 (hu) |
DE (1) | DE69833937T2 (hu) |
DK (1) | DK1017403T3 (hu) |
EA (1) | EA002134B1 (hu) |
EE (1) | EE04953B1 (hu) |
ES (1) | ES2259813T3 (hu) |
HK (1) | HK1025250A1 (hu) |
HU (1) | HU225991B1 (hu) |
IL (1) | IL132214A0 (hu) |
NO (1) | NO328313B1 (hu) |
NZ (1) | NZ500978A (hu) |
PL (1) | PL189526B1 (hu) |
PT (1) | PT1017403E (hu) |
SK (1) | SK284864B6 (hu) |
TW (1) | TW501927B (hu) |
UA (1) | UA62964C2 (hu) |
WO (1) | WO1998048815A1 (hu) |
ZA (1) | ZA983626B (hu) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU225991B1 (en) | 1997-04-29 | 2008-02-28 | Richter Gedeon Nyrt | Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer |
ITPD980168A1 (it) * | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Composizioni biocompatibili e biodegradabili comprendenti acido ialuronico e suoi derivati per il trattamento delle ulcere dell'appara |
HUP0303779A2 (en) * | 2003-11-20 | 2006-02-28 | Richter Gedeon Vegyeszet | Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex |
US8057294B2 (en) * | 2005-09-09 | 2011-11-15 | Wms Gaming Inc. | Wagering game system with community gaming system |
CN100355790C (zh) * | 2005-11-04 | 2007-12-19 | 山东福瑞达生物化工有限公司 | 一种透明质酸锌的制备方法 |
CN100348621C (zh) * | 2005-12-02 | 2007-11-14 | 凌沛学 | 透明质酸铋及其制备方法和应用 |
CN1329414C (zh) * | 2005-12-02 | 2007-08-01 | 凌沛学 | 透明质酸铋钾及其制备方法和应用 |
CN101023961B (zh) * | 2006-02-23 | 2010-07-21 | 山东省生物药物研究院 | 一种含透明质酸钠和锌盐的药物组合物 |
ITMI20061132A1 (it) * | 2006-06-13 | 2007-12-14 | Sinclair Pharmaceuticals Ltd | Composizioni topiche antimicrobiche comprendenti lattoferrina, acido ialuronico o suoi sali ed estratti vegetali |
TWI516269B (zh) * | 2009-08-14 | 2016-01-11 | 禾伸堂生技股份有限公司 | 使用於炎症性腸疾病(ibd)治療和預防之透明質酸混合物 |
TWI383796B (zh) * | 2009-08-14 | 2013-02-01 | Holy Stone Healthcare Co Ltd | Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer |
HUP0900717A3 (en) | 2009-11-18 | 2012-02-28 | Richter Gedeon Nyrt | Pharmaceutical composition for urological use containing zinc hyaluronate |
US20110166099A1 (en) * | 2010-01-04 | 2011-07-07 | Wu Tsung-Chung | Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer |
US8722644B2 (en) | 2010-01-04 | 2014-05-13 | Holy Stone Healthcare Co., Ltd. | Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer |
ES2388281B1 (es) * | 2010-12-27 | 2013-10-01 | Laboratorios Viñas S.A. | Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes |
WO2013129577A1 (ja) * | 2012-03-01 | 2013-09-06 | キユーピー株式会社 | TGF-β発現促進経口剤、痛み物質産生抑制経口剤及び浮腫抑制経口剤 |
US20160287627A1 (en) * | 2013-11-22 | 2016-10-06 | Kewpie Corporation | Method for suppressing onset of gastric ulcer as adverse effect of drug, oral pharmaceutical composition for suppressing onset of gastric ulcer and method for producing the same |
CN104262499A (zh) * | 2014-09-03 | 2015-01-07 | 佐源集团有限公司 | 一种低聚果糖锌及含有低聚果糖锌的口服液 |
CN108051553A (zh) * | 2017-12-29 | 2018-05-18 | 武汉轻工大学 | 一种仔猪肠道功能保护剂的筛选方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1229075B (it) * | 1985-04-05 | 1991-07-17 | Fidia Farmaceutici | Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico |
AU600483B2 (en) * | 1986-03-14 | 1990-08-16 | Bio-Technology General Corporation | Heavy metal salts of hyaluronic acid |
HU203372B (en) | 1989-02-24 | 1991-07-29 | Richter Gedeon Vegyeszet | Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient |
US6458774B1 (en) * | 1989-02-24 | 2002-10-01 | Richter Gedeon Vegyeszeti Gyar Rt. | Compositions containing hyaluronic acid associates and a process for preparing same |
US5472950A (en) | 1989-02-24 | 1995-12-05 | Richter Gedeon Vegyeszeti Gyar Rt. | Compositions containing cobalt hyaluronic acid complex |
JPH0648950A (ja) * | 1992-07-30 | 1994-02-22 | Taito Kk | 抗潰瘍剤 |
HU225329B1 (en) * | 1996-09-12 | 2006-09-28 | Richter Gedeon Vegyeszet | Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity |
HU225991B1 (en) | 1997-04-29 | 2008-02-28 | Richter Gedeon Nyrt | Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer |
-
1997
- 1997-04-29 HU HU9700826A patent/HU225991B1/hu unknown
-
1998
- 1998-04-28 AT AT98920684T patent/ATE320814T1/de active
- 1998-04-28 PL PL98336482A patent/PL189526B1/pl unknown
- 1998-04-28 CN CN98804672A patent/CN1126548C/zh not_active Expired - Fee Related
- 1998-04-28 DE DE69833937T patent/DE69833937T2/de not_active Expired - Lifetime
- 1998-04-28 NZ NZ500978A patent/NZ500978A/en not_active IP Right Cessation
- 1998-04-28 ES ES98920684T patent/ES2259813T3/es not_active Expired - Lifetime
- 1998-04-28 EA EA199900983A patent/EA002134B1/ru not_active IP Right Cessation
- 1998-04-28 KR KR1019997010037A patent/KR100572190B1/ko not_active IP Right Cessation
- 1998-04-28 UA UA99116468A patent/UA62964C2/uk unknown
- 1998-04-28 IL IL13221498A patent/IL132214A0/xx not_active IP Right Cessation
- 1998-04-28 TW TW087106525A patent/TW501927B/zh not_active IP Right Cessation
- 1998-04-28 JP JP54638898A patent/JP2001522361A/ja active Pending
- 1998-04-28 CZ CZ0382799A patent/CZ297317B6/cs not_active IP Right Cessation
- 1998-04-28 PT PT98920684T patent/PT1017403E/pt unknown
- 1998-04-28 BR BR9809354-1A patent/BR9809354A/pt not_active IP Right Cessation
- 1998-04-28 CA CA002286756A patent/CA2286756C/en not_active Expired - Fee Related
- 1998-04-28 EP EP98920684A patent/EP1017403B1/en not_active Expired - Lifetime
- 1998-04-28 DK DK98920684T patent/DK1017403T3/da active
- 1998-04-28 EE EEP199900470A patent/EE04953B1/xx unknown
- 1998-04-28 SK SK1468-99A patent/SK284864B6/sk not_active IP Right Cessation
- 1998-04-28 WO PCT/HU1998/000044 patent/WO1998048815A1/en active IP Right Grant
- 1998-04-28 US US09/403,714 patent/US6656921B1/en not_active Expired - Lifetime
- 1998-04-29 ZA ZA983626A patent/ZA983626B/xx unknown
-
1999
- 1999-10-19 BG BG103822A patent/BG64458B1/bg unknown
- 1999-10-26 NO NO19995229A patent/NO328313B1/no not_active IP Right Cessation
-
2000
- 2000-07-20 HK HK00104494A patent/HK1025250A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9700826A1 (hu) | Peptikus fekély elleni gyógyászati készítmények | |
EE9800080A (et) | (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid | |
TR200200785T2 (tr) | 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri | |
FI964681A (fi) | Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt | |
DK0548114T5 (da) | Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette | |
EP0221041A3 (en) | Benzimidazole derivatives, process for their preparation and their pharmaceutical use | |
AU5669398A (en) | Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them | |
TR200101412T2 (tr) | Yeni bileşikler. | |
DK0695171T3 (da) | Lyosfærer indeholdende gonadotropin | |
KR890700125A (ko) | 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물 | |
HUP9602498A2 (hu) | Antimikrobiális hatású gyógyászati készítmények | |
FI945081A0 (fi) | Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon | |
NL192721B (nl) | Benzonorborneenderivaten, werkwijzen voor het bereiden ervan alsmede geneeskundige en cosmetische preparaten, die dergelijke derivaten bevatten. | |
IL94433A0 (en) | Aminophenol derivatives,their preparation and pharmaceutical compositions containing them | |
MY106202A (en) | Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof. | |
NO972391D0 (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
DK1167354T3 (da) | Racemisk huperzin A | |
MY120683A (en) | New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals. | |
TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
BR0013106A (pt) | Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido. | |
MXPA04005552A (es) | Analogos de vitamina d. | |
AU7775398A (en) | Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions | |
NO973401L (no) | Kortikosteroidinneholdende sammensetninger og fremstilling derav | |
BG102404A (en) | The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system | |
ZA979650B (en) | Heterocyclic compounds, compositions and uses. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC9A | Change of name, address |
Owner name: RICHTER GEDEON NYRT., HU Free format text: FORMER OWNER(S): RICHTER GEDEON VEGYESZETI GYAR RT., HU |